COMMUNIQUÉS West-GlobeNewswire

Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
01/10/2026
Oral presentation will highlight previously reported data demonstrating early stabilization or improvement in mFARS scores among LX2006-treated participants compared with propensity-matched control cohort from UNIFAI [...]
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
01/10/2026
CINCINNATI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2026, on Tuesday, October 27, 2026, following [...]
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
01/10/2026
CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
AONN+ and Manta Cares Partner to Equip Oncology Navigators With AI Tool Purpose-Built for Cancer Patients
01/10/2026
The collaboration provides training, education, and safe AI resources to more than 9,000 oncology nurse and patient navigators nationwide as patients increasingly turn to general purpose AI for cancer information SAN [...]
Vima Therapeutics to Present New Research at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
01/10/2026
Four presentations highlight significant treatment gaps in isolated dystonia and new research providing mechanistic rationale for targeting muscarinic cholinergic receptors for treating movement disorders BOSTON, Oct. [...]
Legato Frames, the World’s First AI-Based Hearing Glasses, Are Now Available in the U.S.
01/10/2026
Designed for the millions of adults seeking a better alternative to traditional hearing aids, Legato Frames integrate AI-powered sound processing into stylish eyewear built for everyday life. BOSTON, Oct. 01, 2026 ( [...]
Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma
01/10/2026
Annual program will award funding to early-career healthcare professionals advancing research, education, and innovation in multiple myeloma BRIDGEWATER, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech [...]
Nox Peptides Announces Expanded Research Focus on BPC-157 and GHK-Cu in Canada
01/10/2026
Toronto, ON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nox Peptides has announced an expanded focus on research-use peptide compounds in Canada, highlighting BPC-157 and GHK-Cu as part of its ongoing efforts to support [...]
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
01/10/2026
PETACH TIKVA, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Health-ISAC® Director of European Operations Elected European Council of ISACs Chair
01/10/2026
Vasileios Mingos to lead cross-sector cyber and physical resilience initiatives across European critical infrastructure networks BRUSSELS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center [...]
Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya
01/10/2026
September 29 shipment follows successful customer inspection and approximately $1.77 million in customer payments received MANKATO, Minn., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES [...]
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
01/10/2026
Jena, Germany, Oct. 01, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced the appointment of [...]
Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies
01/10/2026
Kensington, MD, USA, and Munich/Martinsried, Germany, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Data presented at EURETINA 2026 support high repeatability of patient-tailored microperimetry (MP) for functional evaluation in [...]
Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting
01/10/2026
MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional [...]
OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course
01/10/2026
Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries WARSAW, Ind., Oct. 01, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics [...]
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
01/10/2026
Board additions bring diabetes-development and company-building expertise as Caspian prepares KO-7246 for advancement into clinical testing SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Caspian Therapeutics, Inc. (“ [...]
MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting
01/10/2026
MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62 nd EASD Annual Meeting MTRX31 shown to restore mitochondrial density in the liver of diet-induced [...]
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
01/10/2026
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)- [...]
Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
01/10/2026
Leader in Global Drug Development of T Cell Therapies PHILADELPHIA, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, [...]

Pages